Home / Solutions / Early clinical
Move your program forward with confidence
Early clinical
Success of early clinical trials are linked to strategic planning
Successful early clinical trials depend on strategic design, informed planning, and a clear clinical development roadmap. Certara helps you optimize First-in-Human (FIH) study design, clinical trial protocols, and development plans to minimize risk and improve decision-making. By leveraging our expertise in profiling drug behavior, anticipating variability, and refining trial design, we empower you to enhance success rates and accelerate your path to approval.
Build your evidence and insights
Explore dosing options
Leverage biosimulation to predict responses, analyze data, and refine strategies to design more efficient early-phase trials.
Robust data insights
Transform complex data into actionable insights through advanced pharmacometric modeling and expert consulting services.
Regulatory readiness
Execute your comprehensive clinical development plan, streamline data validation, and prepare regulatory-ready submissions.
Your trusted guide to early clinical success
Certara’s expertise and world-class biosimulation capabilities optimize First-in-Human (FIH) studies and clinical development plans.
- Refine Dosing & Trial Design with industry-leading platforms like Simcyp Simulator and Phoenix PK/PD to enhance decision-making.
- Strengthen Regulatory Submissions using validated standards for trial design, data analysis, and compliance.
- Gain Expert Insights to confirm dosing strategies, assess drug interactions, and predict outcomes in special populations.
Early clinical products
The industry's most trusted PK/PD platform for non-compartmental analysis (NCA), population PK (popPK), IVIVC, and more.
Learn moreSimcyp PBPK provides physiologically based pharmacokinetic modeling to predict drug behavior in diverse populations.
Learn moreSimcyp Biopharmaceutics software is an advanced PBPK platform for biopharmaceutics, formulation, and CMC experts.
Learn moreIncrease the speed and quality of your clinical trial submission data with the Pinnacle 21® Clinical Data Management & Automation Suite.
Learn moreAccelerate the creation of regulatory documents with AI-generated content, freeing up writers for key analysis, messaging, and refinement.
Learn moreUse Certara's AI platform for Life Sciences to solve data silo problems while improving analytics capabilities that boost productivity.
Learn moreEarly clinical services
Our Early Phase Clinical Development solutions provide expert support at every stage, from Candidate Selection through Phase 1.
Learn moreStreamline first-in-human studies with physiologically based modeling to optimize dosing and reduce trial risks.
Learn moreAnalysis and strategies with the main objective of ensuring a successful drug development program.
Learn moreStrategic guidance and end-to-end support to navigate global regulatory pathways, ensuring efficient and compliant drug development from preclinical stages through market approval.
Learn moreBy leveraging quantitative models, regulatory expertise, and real-world data, we empower our partners to fast-track innovative therapies while meeting stringent regulatory standards.
Learn moreCertara is crucial in the majority of trials
From providing the bedrock of predicted pharmacokinetics of cancer drugs to resolving the mass of data from Covid-19 clinical trials, our platforms and consulting provide the prerequisites for success of countless trials and submissions.
Early clinical resources
View allPK/PD Data Analysis, Concepts and Applications eBook
Partner with Certara for early clinical success
Gain a competitive edge with Certara’s world class biosimulation platforms and expert services tailored to your early clinical challenges.
Send an Inquiry
